Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Jonathan B. Brown"'
Autor:
Louis W. Niessen, Andreas Lechner, Rolf Holle, Uta Ferrari, Jonathan B. Brown, Sheikh Mohammed Shariful Islam, Jochen Seissler, Michael Laxy
Publikováno v:
BMJ Global Health
BMJ Glob. Health 2:e000033 (2017)
BMJ Glob. Health 2:e000033 (2017)
Background \ud Diabetes imposes a huge social and economic impact on nations. However, information on the costs of treating and managing diabetes in developing countries is limited. The aim of this study was to estimate healthcare use and expenditure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f68bd9c2166e4b9464ad7ed6bcd4d3d
https://archive.lstmed.ac.uk/6733/1/BMJ_Glob_Heal_2_e000033.pdf
https://archive.lstmed.ac.uk/6733/1/BMJ_Glob_Heal_2_e000033.pdf
Autor:
Kaushik Ramaiya, Clara Bermúdez-Tamayo, Sidibe Assa, Mira Johri, Stéphane Besançon, Jonathan B. Brown
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0176128 (2017)
PLoS ONE, Vol 12, Iss 5, p e0176128 (2017)
Background Diabetes mellitus (DM) is one of the most burdensome chronic diseases and is associated with shorter lifetime, diminished quality of life and economic burdens on the patient and society as a result of healthcare, medication, and reduced la
Autor:
Ping Zhang, Richard Sicree, Xinzhi Zhang, Jonathan B. Brown, Jonathan E. Shaw, Dorte Vistisen, Gregory A. Nichols
Publikováno v:
Diabetes Research and Clinical Practice. 87:293-301
Aims To estimate the global health expenditure on diabetes among people aged 20–79 years for the years 2010 and 2030. Methods Country-by-country expenditures for 193 countries, expressed in United States Dollars (USD) and in International Dollars (
Publikováno v:
Diabetes Care
OBJECTIVE We sought to document the secondary failure rate of metformin monotherapy in a clinical practice setting and to explore factors that predict therapeutic failure. RESEARCH DESIGN AND METHODS We studied 1,799 type 2 diabetic patients who, bet
Publikováno v:
The American Journal of Cardiology. 104:1689-1694
Statin treatment targeting low-density lipoprotein (LDL) cholesterol is widely used for cardiovascular risk reduction, but many statin users still face greatly elevated risks. Some experts advocate additional therapy that targets high-density lipopro
Publikováno v:
Diabetes Care. 30:228-233
OBJECTIVE—We sought to estimate the rate of progression from newly acquired (incident) impaired fasting glucose (IFG) to diabetes under the old and new IFG criteria and to identify predictors of progression to diabetes. RESEARCH DESIGN AND METHODS
Autor:
Gregory A. Nichols, Cynthia J. Girman, Sachin J. Kamal-Bahl, Jonathan B. Brown, Charles M. Alexander
Publikováno v:
Diabetes Care. 29:504-509
OBJECTIVE—To describe secondary failure of initial metformin therapy in patients who achieved initial HbA1c (A1C) RESEARCH DESIGN AND METHODS—We identified 1,288 patients who achieved A1C 8.0% after at least 6 months on metformin. RESULTS—The b
Autor:
Gregory A. Nichols, Jonathan B. Brown
Publikováno v:
Diabetes Care. 28:2223-2229
OBJECTIVE—The purpose of this study was to estimate medical costs associated with elevated fasting plasma glucose (FPG) and to determine whether costs differed for patients who met the 2003 (≥100 mg/dl) versus the 1997 (≥110 mg/dl) American Dia
Publikováno v:
International Journal of Obesity. 28:1365-1373
OBJECTIVE: To examine in middle-aged adults the effect of medical care costs of large, rapid weight gain compared to weight maintenance. DESIGN: Retrospective cohort study for a 3-y time period. SETTING AND PARTICIPANTS: Population-based sample (N=15
Publikováno v:
Diabetes Care. 27:1879-1884
OBJECTIVE—The aims of this study were to update previous estimates of the congestive heart failure (CHF) incidence rate in patients with type 2 diabetes, compare it with an age- and sex-matched nondiabetic group, and describe risk factors for devel